©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Jul 28, 2023; 15(7): 234-240
Published online Jul 28, 2023. doi: 10.4329/wjr.v15.i7.234
Published online Jul 28, 2023. doi: 10.4329/wjr.v15.i7.234
Invasive rhinocerebral mucormycosis: Imaging the temporal evolution of disease in post COVID-19 case with diabetes: A case report
Ramakrishna Narra, Shravya Rayapati, Department of Radiodiagnosis, Katuri Medical College, Guntur, Andhra Pradesh 522018, India
Author contributions: Narra R reviewed the manuscript and designed the study; Rayapati S prepared the manuscript, and collected materials for the study.
Informed consent statement: Informed written consent was obtained from the patient and his relatives for the publication of this report and any accompanying images.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016) and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Ramakrishna Narra, DNB, MD, MNAMS, Academic Editor, Professor, Department of Radiodiagnosis, Katuri Medical College, Flat No. 30, 1/2 Chandramoulinagar, Guntur, Andhra Pradesh 522018, India. narra.ramki29@gmail.com
Received: April 3, 2023
Peer-review started: April 3, 2023
First decision: May 19, 2023
Revised: June 2, 2023
Accepted: June 26, 2023
Article in press: June 26, 2023
Published online: July 28, 2023
Processing time: 111 Days and 23.3 Hours
Peer-review started: April 3, 2023
First decision: May 19, 2023
Revised: June 2, 2023
Accepted: June 26, 2023
Article in press: June 26, 2023
Published online: July 28, 2023
Processing time: 111 Days and 23.3 Hours
Core Tip
Core Tip: Coronavirus disease 2019 associated invasive rhinocerebral mucormycosis is potentially life threatening in patients with uncontrolled diabetes mellitus and diabetic ketoacidosis. Early diagnosis and imaging the disease progression with proper treatment guidelines are essential for reducing the morbidity and mortality in these patients.